Group I (N = 10) | Group II (N = 27) | p value | |
---|---|---|---|
Postoperative ventilation time (hours) | 7.6 ± 4.2 | 17.8 ± 33.7 | 0.700 |
ICU stay (days) | 1.8 ± 0.6 | 3.0 ± 1.7 | 0.025 |
Postoperative hospital stay (days) | 18.3 ± 8.4 | 21.5 ± 13.2 | 0.537 |
LVEF (%) | 46.5 ± 18.6 | 64.3 ± 8.8 | 0.004 |
LVDd (mm) | 51.0 ± 14.2 | 46.2 ± 5.5 | 0.545 |
LVDs (mm) | 38.9 ± 15.3 | 29.8 ± 5.0 | 0.050 |
Change rate of LVEF (%) | −8.7 ± 28.1 | 3.7 ± 18.0 | 0.184 |
Change rate of LVDd (mm) | −11.8 ± 12.1 | −3.4 ± 11.0 | 0.067 |
Change rate of LVDs (mm) | −8.7 ± 12.3 | −2.2 ± 13.3 | 0.198 |
NYHA (1–4) | 1.3 ± 0.5 | 1.3 ± 0.7 | 0.840 |
Complications | |||
Death | 0 (0%) | 1 (3.7%) | 1.000 |
Paravalvular leakage | 0 (0%) | 1 (3.7%) | 1.000 |
Stroke | 1 (10.0%) | 1 (3.7%) | 0.473 |
Late cardiac tamponade | 0 (0%) | 1 (3.7%) | 1.000 |
Reoperation for bleeding | 0 (0%) | 2 (7.4%) | 1.000 |
New onset AF | 0 (0%) | 3 (11.1%) | 0.548 |